Silence Therapeutics (SLN) Depreciation and Depletion: 2020-2025
Historic Depreciation and Depletion for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $81,000.
- Silence Therapeutics' Depreciation and Depletion fell 5.81% to $81,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $311,000, marking a year-over-year decrease of 22.06%. This contributed to the annual value of $336,000 for FY2024, which is 16.00% down from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Depreciation and Depletion is $81,000, which was down 0.00% from $81,000 recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Depreciation and Depletion registered a high of $169,607 during Q1 2021, and its lowest value of $73,000 during Q1 2025.
- Over the past 3 years, Silence Therapeutics' median Depreciation and Depletion value was $86,000 (recorded in 2024), while the average stood at $104,139.
- In the last 5 years, Silence Therapeutics' Depreciation and Depletion slumped by 63.90% in 2021 and then spiked by 91.70% in 2022.
- Quarterly analysis of 5 years shows Silence Therapeutics' Depreciation and Depletion stood at $86,273 in 2021, then skyrocketed by 91.70% to $165,383 in 2022, then dropped by 15.95% to $139,009 in 2023, then plummeted by 45.33% to $76,000 in 2024, then declined by 5.81% to $81,000 in 2025.
- Its last three reported values are $81,000 in Q3 2025, $81,000 for Q2 2025, and $73,000 during Q1 2025.